Halozyme Therapeutics' Unattributed VC Round

Halozyme Therapeutics raised a round of funding on February 23, 2004.

Halozyme (NASDAQ: HALO) is a biopharmaceutical company developing and commercializing products based on the extracellular matrix for the drug delivery, oncology, and dermatology markets.…

Articles about Halozyme Therapeutics' Unattributed VC Round: